药学学报2024,Vol.59Issue(3) :554-564.DOI:10.16438/j.0513-4870.2023-0818

生物传感器分析技术及其在阿尔茨海默病药物研发中的研究进展

Biosensor analysis technology and its research progress in drug development of Alzheimer's disease

沈淑琦 方家豪 王辉 晁亮 游飘雪 洪战英
药学学报2024,Vol.59Issue(3) :554-564.DOI:10.16438/j.0513-4870.2023-0818

生物传感器分析技术及其在阿尔茨海默病药物研发中的研究进展

Biosensor analysis technology and its research progress in drug development of Alzheimer's disease

沈淑琦 1方家豪 1王辉 1晁亮 1游飘雪 2洪战英1
扫码查看

作者信息

  • 1. 海军军医大学药学院,上海市药物(中药)代谢产物重点实验室,上海 200433
  • 2. 福建中医药大学药学院,福建福州 350122
  • 折叠

摘要

生物传感器分析技术是一类可将生物反应转换为光电信号的高特异性技术,在阿尔茨海默病(Alzheimer's disease,AD)药物研发中,针对AD不同假说、不同靶点,该技术在确证靶标、筛选活性化合物方面发挥了重要作用.该文简述AD发病机制与治疗药物现况,重点介绍了 AD药物研发中常用的表面等离子共振技术(surface plasmon resonance,SPR)、生物膜干涉技术(biolayer interferometry,BLI)与荧光分析技术这三类生物传感器分析技术,阐释其基本原理及其应用进展,并总结各自的优势与局限.

Abstract

Biosensor analysis technology is a kind of technology with high specificity that can convert biological reactions into optical and electrical signals.In the development of drugs for Alzheimer's disease(AD),according to different disease hypotheses and targets,this technology plays an important role in confirming targets and screening active compounds.This paper briefly describes the pathogenesis of AD and the current situation of therapeutic drugs,introduces three biosensor analysis techniques commonly used in the discovery of AD drugs,such as surface plasmon resonance(SPR),biolayer interferometry(BLI)and fluorescence analysis technology,explains its basic principle and application progress,and summarizes their advantages and limitations respectively.

关键词

阿尔茨海默病/生物传感器/表面等离子共振技术/生物膜干涉技术/荧光分析技术/药物筛选

Key words

Alzheimer's disease/biosensor/surface plasmon resonance/biolayer interferometry/fluorescence analysis technology/drug screening

引用本文复制引用

基金项目

国家自然科学基金(82173777)

出版年

2024
药学学报
中国药学会 中国医学科学院药物研究所

药学学报

CSTPCD北大核心
影响因子:1.274
ISSN:0513-4870
参考文献量112
段落导航相关论文